PEComa

4 registered clinical trials studyying PEComa.

Status	Trial	Sponsor	Phase
Completed	Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers NCT03190174	Sarcoma Oncology Research Center, LLC	Phase 1 / Phase 2
Active Not Recruiting	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors NCT02834013	National Cancer Institute (NCI)	Phase 2
Completed	Evaluation of New Biomarkers Predictive of Efficacy Betablockers in PEComa and Vascular Pediatric Tumors NCT02334930	University Hospital, Bordeaux	—
Active Not Recruiting	Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients Wi NCT02180867	National Cancer Institute (NCI)	Phase 2 / Phase 3